Long-term safety data from real-world use and extended trials shows that most patients tolerate semaglutide well beyond the initial 12-month period
Has antioxidant properties In addition to the bodys natural aging process, environmental stressors such as stress, UV rays, and pollution can accelerate aging
doi: 10.1186/s12889-025-23475-9, 33
In the SUSTAIN 6 trial (published in the New England Journal of Medicine, 2016), which examined cardiovascular outcomes in over 3,000 patients with type 2 diabetes at high cardiovascular risk, participants receiving semaglutide demonstrated statistically significant reductions in major adverse cardiovascular events
And those are just questions for BPC-157 which seems to be manufactured using solid phase synthesis the risks multiply exponentially for any peptides manufactured biologically
Realistic expectation is improvement of small magnitude